CSChiara Sileo

Chiara Sileo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chiara Sileo has a total of 153 co-authors. Here are the top co-authors by number of shared publications:

  • Hubert Ducou Le Pointe

    Hôpital d’enfants Armand-Trousseau

    6 shared publications
  • Nadia Nathan

    Sorbonne Université, Pediatric Pulmonology and Reference Center for rare lung diseases RespiRare, Inserm U933 Laboratory of childhood genetic diseases, Armand Trousseau Hospital, APHP, Paris, France

    5 shared publications
  • Annick Clement

    RaDiCo, Inserm, Trousseau Hospital, Paris, France

    3 shared publications
  • H. Ducou le Pointe

    Department of radiology, hôpital Armand-Trousseau, université Pierre-et-Marie-Curie, Assistance publique-Hôpitaux de Paris (AP-HP), Paris VI, France

    3 shared publications
  • Harriet Corvol

    Inserm U938, Centre de Recherche Saint‐Antoine (CRSA), Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Trousseau, Service de Pneumologie Pédiatrique Sorbonne Université Paris France

    3 shared publications
  • Ralph Epaud

    Paediatric Department, Centre Hospitalier Intercommunal de Créteil, Reference Centre for Rare Lung Diseases (RespiRare®), University Paris Est Créteil, INSERM, IMRB , Créteil

    3 shared publications

Latest Publications

  • Open Access

    ESR Essentials: imaging of common paediatric pulmonary diseases—practice recommendations by the European Society of Paediatric Radiology

    by Jovan Lovrenski, Maria Raissaki, Domen Plut, Efthymia Alexopoulou, Süreyya Burcu Görkem, H. Nursun Ozcan, Julia Geiger, Daniel Gräfe, Chiara Sileo, Pablo Caro-Dominguez, et al.

    Chest imaging in children presents unique challenges due to varying requirements across age groups. For chest radiographs, achieving optimal images often involves careful positioning and immobilisation techniques. Antero-posterior projections are easier to obtain in younger children, while lateral decubitus radiographs are sometimes used when expiratory images are difficult to obtain and for free air exclusion. Chest CT protocols should be age-dependent to minimise radiation exposure and motion artefacts. MRI is primarily used in specialised centres to reduce radiation exposure, requiring specific expertise and sedation in younger children. Respiratory distress syndrome is a leading cause of morbidity in preterm neonates, diagnosed through characteristic radiographic findings and a history of prematurity. Bronchopulmonary dysplasia is the most common complication of extreme preterm birth and chronic oxygen therapy; imaging is used for predicting outcomes for the assessment of severe cases. Transient tachypnoea of the newborn and meconium aspiration syndrome are common in term infants, with specific imaging characteristics aiding in their differentiation. Congenital lung malformations present diagnostic and management challenges, with imaging playing a crucial role in diagnosis and surgical planning. Finally, imaging is essential in detecting complications from pneumonia in children, such as empyema and necrotic pneumonia, or in identifying foreign object aspiration. Clinical relevance statement: This review summarises current radiology practice of paediatric chest pathologies, aiding in the accurate diagnosis and management of neonatal and congenital pulmonary conditions and pneumonia complications, ultimately improving patient outcomes through precise imaging interpretation and targeted clinical intervention. Key Points: Chest radiographs should be systematically assessed for pathology. Ensure accurate differential diagnosis of neonatal lung diseases by collecting information on gestational age, method of delivery, presenting symptoms, ventilation type, and fetal ultrasound findings. Radiographs and ultrasound are initial diagnostic tools for paediatric pulmonary disease; CT should be reserved for complex cases. Referral to paediatric hospital should be considered when the use of chest MRI is indicated.


  • Cardiac MRI in Children with Multisystem Inflammatory Syndrome Associated with COVID-19

    by Eléonore Blondiaux, Pauline Parisot, Alban Redheuil, Lucile Tzaroukian, Yaël Levy, Chiara Sileo, Aurélie Schnuriger, Mathie Lorrot, Romain Guedj, Hubert Ducou le Pointe

    This case series examines cardiac MRI findings in four children and adolescents admitted to intensive care in April 2020 for multisystem inflammatory syndrome and Kawasaki disease-like features rel...


  • Open Access

    The Wide Spectrum of COVID-19 Clinical Presentation in Children

    by Nadia Nathan, Blandine Prevost, Chiara Sileo, Nicolas Richard, Laura Berdah, Guillaume Thouvenin, Guillaume Aubertin, Thibault Lecarpentier, Aurélie Schnuriger, Julien Jegard, et al.

    Background: Ten months after its appearance in December 2019, SARS-CoV-2 has infected more than 25 million patients worldwide. Because children were first identified as potential spreaders of the virus, schools were closed in several countries. However, it rapidly became evident that the number of hospitalized children infected by SARS-CoV-2 was dramatically lower than that of adults. To date, only hypotheses have been raised to explain this difference, so it is of great importance to describe the presentation of this disease among children. Here, we describe a wide spectrum of COVID-19 manifestation in children in a dedicated pediatric unit in France. Methods: Patients hospitalized with COVID-19 who were diagnosed on the basis of either positive SARS-CoV-2 RT-PCR in nasopharyngeal swabs and/or typical aspects in chest-computed tomography (CT) were included between March and May 2020 in Paris. Results: Twenty-three patients were included on the basis of positive RT-PCR (n = 20) and/or typical aspects in CT (n = 4). The median age was 4.9 years [0.1–17.6]. Patients were grouped by age (10 years old: n = 7, 30%). Overweight or obesity was reported in only three patients. At presentation, the most frequent symptom in the overall cohort was fever (n = 18, 78%), followed by acute rhinitis (n = 9, 64%) and cough (n = 7, 50%) in the under 2-year-old group and cough (n = 4, 57%), fatigue, dyspnea and abdominal pain (n = 3, 43% each) in the over 10-year-old group. Five patients required ICU treatment, four of whom were aged >10 years, two presented with acute myocarditis, and two were sickle cell disease patients who presented with acute chest syndrome. Discussion and conclusion: The youngest patients seem to present milder forms of COVID-19 without the need for ICU treatment and with a shorter length of hospitalization. More severe evolutions were observed in teenagers, with, however, favorable outcomes. Given the context of closed schools and confinement, the infection of these children suggests intra-familial transmission that needs to be further assessed. This description might help to understand the intriguing differences in COVID-19 severity across age-classes.


  • Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis

    by Valeria Della Valle, Jean Donadieu, Chiara Sileo, Mohamed Aziz Barkaoui, Sébastien Héritier, Hervé Brisse, Nathalie Boutry, Catherine Tréguier, Jean‐François Chateil, Philippe Petit, et al.

    Objective: This study was undertaken to describe the spectrum of lung computed‐tomography (CT) findings in children with pulmonary Langerhans cell histiocytosis (PLCH) and to evaluate for this population the CT‐scan nodule and cyst scores proposed by adult pulmonologists at diagnosis and during follow‐up.Methods: Among 175 children with PLCH identified in the French national population‐based Langerhans cell histiocytosis cohort, 60 were retrospectively selected by the availability of CT for a central review by three pediatric radiologists. These 60 patients are representative of childhood PLCH for almost all clinical aspects, except a lower percentage of risk organ involvement (38% vs 54%; P = 0.05).Results: The 60 children's chest CT scans (n = 218) were reviewed. At diagnosis, 63% of them had nodules, 53% had cysts, and 29% had both. The percentages of patients with nodules or cysts increased from diagnosis to peak disease activity, respectively, from 63% to 73% and from 53% to 66%. The costophrenic angle was involved in 71%. Patients with pneumothorax (25%) had a higher median cyst score. Alveolar consolidation was observed in 34%. Patients with low CT‐scan nodule and cyst scores had no long‐term pulmonary sequelae.Conclusions: Well‐known characteristics of adult PLCH (nodules and cysts) were observed in children. The chest CT scores proposed by adult pulmonologists could easily be applied to childhood PLCH. Lesions in children, unlike those in adults, are frequently located near the costophrenic angles. Alveolar consolidation might be considered an atypical feature of childhood PLCH.


  • Interstitial lung diseases in children

    by Nadia Nathan, Laura Berdah, Céline Delestrain, Chiara Sileo, Annick Clement


  • Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage

    by Marie-Louise Frémond, Marie Legendre, Michael Fayon, Annick Clement, Emilie Filhol-Blin, Nicolas Richard, Laura Berdah, Sylvie Roullaud, Gillian I Rice, Vincent Bondet, et al.

    COPA (coatomer subunit α) syndrome is a newly recognised cause of interstitial lung disease in children and adults, frequently associated with arthritis and renal dysfunction. We report a 11-year-old girl with disease limited to major pulmonary haemosiderosis manifesting at the age of 2 years, due to a heterozygous p.(Arg233His) mutation inCOPA. Her interferon (IFN) signature was elevated (10.312 and 12.429, healthy COPAscreening. Functional tests can help to personalise patient therapy.


  • Open Access

    Pulmonary Fibrosis in Children

    by Nadia Nathan, Chiara Sileo, Guillaume Thouvenin, Laura Berdah, Céline Delestrain, Effrosyne Manali, Spyros Papiris, Pierre-Louis Léger, Hubert Ducou le Pointe, Aurore Coulomb L’hermine, et al.

    Pulmonary fibrosis (PF) is a very rare condition in children, which may be observed in specific forms of interstitial lung disease. None of the clinical, radiological, or histological descriptions used for PF diagnosis in adult patients, especially in situations of idiopathic PF, can apply to pediatric situations. This observation supports the view that PF expression may differ with age and, most likely, may cover distinct entities. The present review aims at summarizing the current understanding of PF pathophysiology in children and identifying suitable diagnostic criteria.


  • Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAFV600E mutation study from the French national cohort

    by Marianne Kambouchner, Jean-François Emile, Marie-Christine Copin, Aurore Coulomb-Lherminé, Jean-Christophe Sabourin, Valeria Della Valle, Chiara Sileo, Hubert Ducou Le Pointe, Hugues Bégueret, Louise Galmiche, et al.


  • Paediatric sarcoidosis

    by Nadia Nathan, Chiara Sileo, Alain Calender, Yves Pacheco, Paul-André Rosental, Catherine Cavalin, Odile Macchi, Dominique Valeyre, Annick Clement


  • Open Access

    Prognostic value of cerebral tissue oxygen saturation during neonatal extracorporeal membrane oxygenation

    by Marie-Philippine Clair, Jérôme Rambaud, Adrien Flahault, Romain Guedj, Julia Guilbert, Isabelle Guellec, Amélie Durandy, Maryne Demoulin, Sandrine Jean, Delphine Mitanchez, et al.

    Extracorporeal membrane oxygenation support is indicated in severe and refractory respiratory or circulatory failures. Neurological complications are typically represented by acute ischemic or hemorrhagic lesions, which induce higher morbidity and mortality. The primary goal of this study was to assess the prognostic value of cerebral tissue oxygen saturation (StcO2) on mortality in neonates and young infants treated with ECMO. A secondary objective was to evaluate the association between StcO2 and the occurrence of cerebral lesions. This was a prospective study in infants < 3 months of age admitted to a pediatric intensive care unit and requiring ECMO support. The assessment of cerebral perfusion was made by continuous StcO2 monitoring using near-infrared spectroscopy (NIRS) sensors placed on the two temporo-parietal regions. Neurological lesions were identified by MRI or transfontanellar echography. Thirty-four infants 2 during ECMO in the non-survivors was reduced in both hemispheres (p = 0.0008 right, p = 0.03 left) compared to the survivors. StcO2 was also reduced in deceased or brain-injured patients compared to the survivors without brain injury (p = 0.002). StcO2 appears to be a strong prognostic factor of survival and of the presence of cerebral lesions in young infants during ECMO.